Your shopping cart is currently empty

Ruzinurad (WO2020088641, compound I) is a potent URAT1 inhibitor, exhibiting high selectivity. This compound shows great promise for investigating hyperuricemia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $913 | Inquiry | Inquiry | |
| 100 mg | $1,490 | Inquiry | Inquiry |
| Description | Ruzinurad (WO2020088641, compound I) is a potent URAT1 inhibitor, exhibiting high selectivity. This compound shows great promise for investigating hyperuricemia. |
| In vitro | Ruzinurad is a highly selective URAT1 inhibitor, exhibiting significant activity in reducing serum urate levels in hyperuricemic patients by effectively blocking the URAT1 (urate transporter 1) protein to enhance uric acid excretion, thereby mitigating the risk of gout and related conditions. [1] |
| Molecular Weight | 338.22 |
| Formula | C14H12BrNO2S |
| Cas No. | 1638327-48-6 |
| Smiles | OC(=O)C1(CCC1)Sc1ccnc2ccc(Br)cc12 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.